Frankfurt
21.04.26 | 11:01
0,014 Euro
+300,00 % +0,011
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,005 | 0,018 | 12:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Verici Dx PLC - Positive Q1 Trading Update | - | RNS | ||
| 10.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 07.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| VERICI DX Aktie jetzt für 0€ handeln | |||||
| 31.03. | Verici Dx PLC - Board Change | - | RNS | ||
| 30.03. | Verici Dx PLC - Holding(s) in Company | 1 | RNS | ||
| 05.02. | Verici Dx reports $3.8m revenue for FY25, driven by Tutivia test sales | 2 | Investing.com | ||
| 05.02. | Verici Dx PLC - FY25 Trading Update | - | RNS | ||
| 05.02. | Verici Dx PLC - Agreement with BCBS of Illinois for Tutivia | - | RNS | ||
| 12.11.25 | Verici Dx PLC - Completion of CAP accreditation audit | - | RNS | ||
| 06.11.25 | Verici Dx PLC - Provider Participation Agreement with Prime Health | - | RNS | ||
| 03.11.25 | TRADING UPDATES: Northcoders contract wins; Verici Dx completes audit | 1 | Alliance News | ||
| 03.11.25 | Verici Dx PLC - Completion of ISO 27001 surveillance audit | - | RNS | ||
| 30.10.25 | Verici Dx revises option pricing, grants new share options | 2 | Investing.com | ||
| 30.10.25 | Verici Dx PLC - Options revision & Grant of new share options | - | RNS |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDIGENE | 0,021 | -16,41 % | Medigene: Zurückziehung - 18.11.2025 | ||
| CO.DON | 0,014 | -18,18 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp: Sirona Biochem to be delisted from NEX on April 21 | ||
| TME PHARMA | 0,076 | +19,59 % | TME Pharma NV: TME Pharma Announces Publication of NOX-A12 "Triple Therapy" Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications | TME Pharma Announces Publication of NOX-A12 "Triple Therapy" Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications Berlin, Germany, April 16, 2026, 08.00am CET - TME Pharma... ► Artikel lesen | |
| REPLENISH NUTRIENTS | 0,092 | +3,37 % | Replenish Nutrients Holding Corp: Replenish to receive $250,000 grant | ||
| GLOW LIFETECH | 0,027 | 0,00 % | Glow Lifetech Corp.: Glow Lifetech Reports Fourth Quarter and Full Year 2025 Financial Results; 146% YoY Revenue Growth and Second Consecutive Quarter of Positive Cash Flow | Toronto, Ontario--(Newsfile Corp. - April 8, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth... ► Artikel lesen | |
| ADAPTIMMUNE THERAPEUTICS | 0,013 | 0,00 % | Adaptimmune Therapeutics PLC: Adaptimmune Announces Changes to Board and Executive Leadership Team | Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - November 17, 2025) - Adaptimmune Therapeutics plc (OTC Pink: ADAPY) ("Adaptimmune" or the "Company") today announced changes... ► Artikel lesen | |
| NEOVACS | 0,000 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.04.2026 | Das Instrument B4A1 CH0208062627 MEIER TOBLER GRP AG NAM. EQUITY wird cum Kapitalmassnahme gehandelt am 08.04.2026 und ex Kapitalmassnahme am 09.04.2026 The instrument B4A1 CH0208062627 MEIER TOBLER... ► Artikel lesen | |
| BIOVAXYS TECHNOLOGY | 0,038 | 0,00 % | Biovaxys Technology Corp (2): Biovaxys Technology has no material changes | ||
| TELO GENOMICS | 0,039 | +8,33 % | Telo Genomics Corp.: Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma | Vancouver, British Columbia--(Newsfile Corp. - April 14, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and... ► Artikel lesen | |
| ALTERITY THERAPEUTICS | 0,007 | 0,00 % | ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors | MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing... ► Artikel lesen | |
| MEDMIRA | 0,035 | 0,00 % | MedMira, Inc.: MedMira Reports Second Quarter Results FY2025 | HALIFAX, NS / ACCESS Newswire / April 1, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026.Corporate updateIn Q2 FY2026, the Company... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Long Term Suspended Entities | ||
| BIOPHYTIS | 0,016 | -0,62 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.12.2025 | Das Instrument 6XB3 FR001400OLP5 BIOPHYTIS NAM. EO -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 09.12.2025 und ex Kapitalmassnahme am 10.12.2025 The instrument 6XB3 FR001400OLP5 BIOPHYTIS NAM.... ► Artikel lesen | |
| ACTIVE BIOTECH | 0,007 | -4,35 % | Active Biotech AB: Active Biotech Year End Report 2025 | FOURTH QUARTER IN BRIEFActive Biotech announced a fully secured rights issue, subject to approval by an extraordinary general meeting, of approximately SEK 70 million before transaction costs (October... ► Artikel lesen |
Das Unternehmen VERICI DX PLC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,014 Euro und damit +300,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VERICI DX PLC finden Sie auf Wallstreet Online.